Calumet Specialty Ownership

CLMT Stock  USD 12.22  0.45  3.55%   
Calumet Specialty holds a total of 86.21 Million outstanding shares. Calumet Specialty Products retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2005-09-30
Previous Quarter
85.5 M
Current Value
86.1 M
Avarage Shares Outstanding
59 M
Quarterly Volatility
24.7 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Dividend Yield is likely to drop to 0.1 in 2025. Dividend Payout Ratio is likely to gain to -0.14 in 2025. Common Stock Shares Outstanding is likely to drop to about 54 M in 2025. Net Loss is likely to gain to about (141.2 M) in 2025.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Calumet Specialty Products. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Calumet Stock Ownership Analysis

About 21.0% of the company shares are held by company insiders. The company has Price/Earnings To Growth (PEG) ratio of 2.71. Calumet Specialty recorded a loss per share of 2.67. The entity last dividend was issued on the 29th of January 2016. The firm had 1:1 split on the 11th of July 2024. Calumet Specialty Products Partners, L.P. manufactures, formulates, and markets slate of specialty branded products to various consumer-facing and industrial markets in North America and internationally. The company was founded in 1916 and is headquartered in Indianapolis, Indiana. Calumet Specialty operates under Oil Gas EP classification in the United States and is traded on NASDAQ Exchange. It employs 1450 people. For more info on Calumet Specialty Products please contact Louis Borgmann at 317-328-5660 or go to https://calumet.com.
Besides selling stocks to institutional investors, Calumet Specialty also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Calumet Specialty's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Calumet Specialty's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Calumet Specialty Quarterly Liabilities And Stockholders Equity

2.76 Billion

Calumet Specialty Insider Trades History

About 21.0% of Calumet Specialty Products are currently held by insiders. Unlike Calumet Specialty's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Calumet Specialty's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Calumet Specialty's insider trades
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Calumet Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Calumet Specialty is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Calumet Specialty Products backward and forwards among themselves. Calumet Specialty's institutional investor refers to the entity that pools money to purchase Calumet Specialty's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Group One Trading, Lp2024-12-31
517.7 K
Garnet Capital Holdings, Inc.2024-12-31
455.6 K
Arrowpoint Investment Partners (singapore) Pte. Ltd.2024-12-31
449.5 K
Charles Schwab Investment Management Inc2024-12-31
405.7 K
Goldman Sachs Group Inc2024-12-31
348.5 K
Marshall Wace Asset Management Ltd2024-12-31
320 K
Royal Bank Of Canada2024-12-31
310.5 K
Barnett & Co Inc2024-12-31
278.9 K
Vanderbilt University2024-12-31
212.6 K
Wasserstein Debt Opportunities Management Lp2024-12-31
5.7 M
Adams Asset Advisors Llc2024-12-31
5.3 M
Note, although Calumet Specialty's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Calumet Specialty Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Calumet Specialty insiders, such as employees or executives, is commonly permitted as long as it does not rely on Calumet Specialty's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Calumet Specialty insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Schumacher Amy M over a week ago
Acquisition by Schumacher Amy M of 517 shares of Calumet Specialty subject to Rule 16b-3
 
Scott Obermeier over a week ago
Disposition of 13993 shares by Scott Obermeier of Calumet Specialty subject to Rule 16b-3
 
Louis Borgmann over a week ago
Disposition of 114120 shares by Louis Borgmann of Calumet Specialty subject to Rule 16b-3
 
Stephen Mawer over two weeks ago
Disposition of 3655 shares by Stephen Mawer of Calumet Specialty at 12.64 subject to Rule 16b-3
 
David Lunin over three weeks ago
Acquisition by David Lunin of 37463 shares of Calumet Specialty subject to Rule 16b-3
 
Straumins Jennifer over three months ago
Disposition of 8921 shares by Straumins Jennifer of Calumet Specialty subject to Rule 16b-3
 
Stephen Mawer over three months ago
Disposition of 15037 shares by Stephen Mawer of Calumet Specialty at 17.87 subject to Rule 16b-3
 
Louis Borgmann over three months ago
Disposition of 900 shares by Louis Borgmann of Calumet Specialty at 20.0 subject to Rule 16b-3
 
Gregory Morical over three months ago
Disposition of 11111 shares by Gregory Morical of Calumet Specialty at 15.04 subject to Rule 16b-3
 
Sajkowski Daniel J over six months ago
Acquisition by Sajkowski Daniel J of 7490 shares of Calumet Specialty subject to Rule 16b-3
 
Carter James S over six months ago
Acquisition by Carter James S of 531 shares of Calumet Specialty subject to Rule 16b-3
 
Bruce Fleming over six months ago
Disposition of 12773 shares by Bruce Fleming of Calumet Specialty subject to Rule 16b-3

Calumet Specialty Outstanding Bonds

Calumet Specialty issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Calumet Specialty uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Calumet bonds can be classified according to their maturity, which is the date when Calumet Specialty Products has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Calumet Specialty Corporate Filings

19th of March 2025
Other Reports
ViewVerify
8K
18th of March 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
13th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
10K
3rd of March 2025
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
ViewVerify

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Calumet Stock Analysis

When running Calumet Specialty's price analysis, check to measure Calumet Specialty's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calumet Specialty is operating at the current time. Most of Calumet Specialty's value examination focuses on studying past and present price action to predict the probability of Calumet Specialty's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calumet Specialty's price. Additionally, you may evaluate how the addition of Calumet Specialty to your portfolios can decrease your overall portfolio volatility.